FI864480A0 - Medel foer oekande av proteinabsorption. - Google Patents

Medel foer oekande av proteinabsorption.

Info

Publication number
FI864480A0
FI864480A0 FI864480A FI864480A FI864480A0 FI 864480 A0 FI864480 A0 FI 864480A0 FI 864480 A FI864480 A FI 864480A FI 864480 A FI864480 A FI 864480A FI 864480 A0 FI864480 A0 FI 864480A0
Authority
FI
Finland
Prior art keywords
proteinabsorption
oekande
medel foer
medel
foer
Prior art date
Application number
FI864480A
Other languages
English (en)
Other versions
FI864480A (fi
Inventor
Stanley Jay Sarnoff
Burton E Sobel
Original Assignee
Survival Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,845 external-priority patent/US4661469A/en
Priority claimed from US06/782,441 external-priority patent/US4772585A/en
Application filed by Survival Technology filed Critical Survival Technology
Publication of FI864480A publication Critical patent/FI864480A/fi
Publication of FI864480A0 publication Critical patent/FI864480A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI864480A 1985-03-06 1986-11-04 Medel foer oekande av proteinabsorption. FI864480A0 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/708,845 US4661469A (en) 1984-08-08 1985-03-06 t-PA composition capable of being absorbed into the blood stream and method of administration
US71670585A 1985-03-27 1985-03-27
US06/782,441 US4772585A (en) 1984-08-08 1985-10-01 Protein thrombolytic agent with absorption enhancing agent
PCT/US1986/000475 WO1986005096A1 (en) 1985-03-06 1986-03-06 Protein absorption enhancing agents

Publications (2)

Publication Number Publication Date
FI864480A FI864480A (fi) 1986-11-04
FI864480A0 true FI864480A0 (fi) 1986-11-04

Family

ID=27418848

Family Applications (1)

Application Number Title Priority Date Filing Date
FI864480A FI864480A0 (fi) 1985-03-06 1986-11-04 Medel foer oekande av proteinabsorption.

Country Status (9)

Country Link
EP (1) EP0214281B1 (fi)
AT (1) ATE80306T1 (fi)
AU (1) AU593794B2 (fi)
DE (1) DE3686684T2 (fi)
DK (1) DK528386A (fi)
FI (1) FI864480A0 (fi)
HU (1) HUT41632A (fi)
NO (1) NO864382D0 (fi)
WO (1) WO1986005096A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839170A (en) * 1985-10-01 1989-06-13 Survival Technology, Inc. Protein absorption enhancing agents
DE3544663A1 (de) * 1985-12-13 1987-06-19 Schering Ag Thrombosebehandlung mit fibrinolytika und prostacyclinen
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78571A (en) * 1985-04-22 1991-06-30 Genentech Inc Human tissue plasminogen activator mutants resistant to enzymatic cleavage resulting in two-chain form
NL8601354A (nl) * 1985-05-28 1986-12-16 Wellcome Found Nieuwe samenstelling.

Also Published As

Publication number Publication date
FI864480A (fi) 1986-11-04
DK528386D0 (da) 1986-11-05
DE3686684D1 (de) 1992-10-15
HUT41632A (en) 1987-05-28
ATE80306T1 (de) 1992-09-15
EP0214281B1 (en) 1992-09-09
WO1986005096A1 (en) 1986-09-12
EP0214281A1 (en) 1987-03-18
AU5581186A (en) 1986-09-24
EP0214281A4 (en) 1989-03-16
DE3686684T2 (de) 1993-01-28
AU593794B2 (en) 1990-02-22
NO864382D0 (no) 1986-11-03
NO864382L (no) 1986-03-11
DK528386A (da) 1986-11-05

Similar Documents

Publication Publication Date Title
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
IL97411A (en) Pharmaceutical formulations comprising hapten-modified diagnostic or therapeutic agents
NO833769L (no) Immunogent protein- eller peptidkompleks, fremgangsmaate for fremstilling og anvendelse herav som immunstimulerende middel og som vaksine
NL193981B (nl) 7-(eventueel gesubstitueerd naftyl)-3-methyl-octa-2,4,6-trieenderivaten met retineachtige werking alsmede farmaceutische en kosmetische preparaten die dergelijke derivaten bevatten.
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
EP0191056A4 (en) T-PA COMPOSITION AND METHOD FOR ITS INCORPORATION INTO THE BLOOD FLOW.
DK317288D0 (da) Hybridprotein af humant protein c og dets fremstilling samt dna, som koder det
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ES2059588T3 (es) Factor xiii para la prevencion de una hemorragia intraventricular.
FI864480A (fi) Medel foer oekande av proteinabsorption.
DK325289D0 (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
ATE206458T1 (de) T-zellen stimulierendes protein von pestivirus
FI874273A (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
AU4721185A (en) Protein absorption enhancing agents
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
NO166225C (no) Fluorborsyresalt av n-tridecyl-2,6-dimetylmorfolin, fungicid og trebeskyttelsesmiddel inneholdende dette, samt anvendelse derav.
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use
DE3674517D1 (de) Cyklisches oxim.
NO872633D0 (no) Monoklonalt antistoff mot humant plasminogen, samt fremstilling derav.
BR6802052U (pt) Mascara cirurgica descartavel retangular com cadarcos costurados pelo sistema hrow(hight resfst one way)
NO864689D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive peptider.
IT207181Z2 (it) Flaconcino con cannula sigillata monouso.
ES522243A0 (es) Procedimiento para la preparacion de mezclas de liquidos farmaceuticos,particularmente soluciones de infusion

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: SURVIVAL TECHNOLOGY, INC.